Physician

Justin Thomas Lloyd Baynham, MD

According to 2025 Medicare claims, Justin Baynham, MD (NPI: 1750516928) practices ophthalmology in the Salem, OR market, with the plurality of this provider's patient population coming from Marion, OR. This provider's primary affiliated billing organization is RETINA CONSULTANTS, LLP (NPI: 1528181674; TIN: 93-1152985) and primary practice location at 97302-2152.

Baynham's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 496 traditional Medicare patients, billed 17,910 HCPCS/CPT codes, and received $1,337,815 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 418 prescription claims across 130 beneficiaries totaling $10,718 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 2 records totaling $50. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$835K$1.7M2015 Medicare payment: $407,196 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,343,788 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,316,344 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,498,766 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,670,146 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,566,227 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,666,387 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,652,076 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,399,839 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,337,815 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153761,957$407,196
20166126,449$1,343,788
20176347,516$1,316,344
20186277,975$1,498,766
20195816,910$1,670,146
20205027,056$1,566,227
20215286,623$1,666,387
20224478,950$1,652,076
202346317,928$1,399,839
202449617,910$1,337,815

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$7.7K$15K2015 Drug cost: $15,318 (USD; Tot_Drug_Cst)2016 Drug cost: $12,938 (USD; Tot_Drug_Cst)2017 Drug cost: $9,519 (USD; Tot_Drug_Cst)2018 Drug cost: $12,575 (USD; Tot_Drug_Cst)2019 Drug cost: $11,953 (USD; Tot_Drug_Cst)2020 Drug cost: $11,565 (USD; Tot_Drug_Cst)2021 Drug cost: $13,167 (USD; Tot_Drug_Cst)2022 Drug cost: $12,716 (USD; Tot_Drug_Cst)2023 Drug cost: $12,289 (USD; Tot_Drug_Cst)2024 Drug cost: $10,718 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015124387$15,318
2016137541$12,938
2017136467$9,519
2018144552$12,575
2019128486$11,953
2020114422$11,565
2021109386$13,167
2022114385$12,716
2023120396$12,289
2024130418$10,718

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system147147$97
67028Injection of drug into eye204784$95
92014Established patient complete exam of visual system302400$89
92012Established patient problem focused exam of visual system152235$66
92134Imaging of retina4151,070$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1053,619$4,653
Ketorolac TromethamineKetorolac Tromethamine401,544$1,581
Atropine SulfateAtropine Sulfate521,362$1,163
LatanoprostLatanoprost443,035$1,013
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat584,517$739

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$50ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Justin Thomas Lloyd Baynham, MD?

Tedicare shows public-source Medicare data for Justin Thomas Lloyd Baynham, MD (NPI 1750516928), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Justin Thomas Lloyd Baynham, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Justin Thomas Lloyd Baynham, MD?

Justin Thomas Lloyd Baynham, MD is linked to RETINA CONSULTANTS, LLP (billing NPI 1528181674) in the available physician profile data.

Does Justin Thomas Lloyd Baynham, MD have Open Payments data?

Justin Thomas Lloyd Baynham, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.